Delivery Order SPE2DB22D3010-SPE2DB25FP1JT

Award Date 1/14/25
Potential Completion Date 2/5/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,375.85 with a Firm Fixed Price pricing type. The ultimate completion date is December 13, 2024. The contract covers the procurement of ORGOVYX 120 MG TABLET, a pharmaceutical product, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 Firm Fixed Price Delivery Order is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, with a period of performance through January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET to support the agency's medical requirements. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract, awarded on February 19, 2025, is for the supply of ORGOVYX 120 MG TABLET medication with a performance period through March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET. The contract has an ultimate completion date of February 4, 2025 and is not designated as a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,659.78, is a Firm Fixed Price Delivery Order for the provision of ORGOVYX 120 MG TABLET. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,313.12 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET medication, with a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,375.85, is a Firm Fixed Price Delivery Order for the pharmaceutical product ORGOVYX 120 MG TABLET. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET medication. The contract has an ultimate completion date of December 11, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,375.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of December 27, 2024. The contract provides for the delivery of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product, to support military healthcare programs globally. Amerisourcebergen holds a...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB25FP1JT
    Delivery Order

This federal contract award, with the ID SPE2DB22D3010|SPE2DB25FP1JT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $1,375.85 and is a Firm Fixed Price Delivery Order contract running through February 5, 2025.

The contract covers the procurement of the pharmaceutical product ORGOVYX 120 MG Tablet, which is used in the treatment of various medical conditions. As an open competition contract with no set-aside designation, AmerisourceBergen was selected as the prime contractor based on their extensive capabilities in distributing a comprehensive range of pharmaceutical products and medical supplies to federal government agencies, particularly within military and veterans' healthcare systems.

In addition to this specific contract award, AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a wide array of critical pharmaceutical and medical commodities to support military healthcare programs globally.

Generated 5/21/25, 10:06 AM